Mass Tort News

Last week, the U.S. Food and Drug Administration (FDA) issued a letter to Bayer indicating requirements for submitting adverse event reports and postmarket activities associated with …

Defendants named in the Risperdal gynecomastia litigation, Johnson & Johnson, and its Janssen Pharmaceuticals subsidiary, will now have to compensate thousands of Risperdal…

A request has been put before the New Jersey Supreme Court by both parties of Abilify litigation for the creation of a Multicounty Litigation (MCL) to ensure that future…

The Johnson & Johnson’s Talcum powder case in which the verdict of $72 million was dismissed in October 2017 was put forth for an appeal by the family of the…

Just when Xarelto plaintiff attorneys were rejoicing and preparing on the lines of the first Philadelphia Xarelto trial which brought in the first-ever win for the…

Invokana, (a diabetic medication and  SGLT2 inhibitor) was also in the news as the FDA now requires a serious boxed warning to be highlighted in the labels about the increased risk of leg and foot amputations. This…

Despite winning its first trial in November 2017, Testim gel makers, Auxilium, settled a lawsuit for an undisclosed amount, just days before the trial in Pennsylvania’s Philadelphia Court of Common Pleas. Allegations put forth by the…

The FDA has shown no signs or indications regarding any ban on transvaginal mesh devices used to treat pelvic organ prolapse (POP) and stress urinary…

Portola Pharmaceuticals received news of a second-time delay from the U.S. Food & Drug Administration (FDA) regarding the approval of AndexXa, an antidote developed to monitor uncontrollable bleeding linked to Xarelto and Eliquis.…

Eli Lilly and Company, the maker of Axiron used in the treatment of low testosterone levels is one of the defendants in the over 6,000 centralized …